Infinity Pharmaceuticals Inc (INFI.OQ)
INFI.OQ on NASDAQ Stock Exchange Global Select Market
1.24USD
8:59pm GMT
1.24USD
8:59pm GMT
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$1.24
$1.24
Open
$1.22
$1.22
Day's High
$1.27
$1.27
Day's Low
$1.22
$1.22
Volume
31,705
31,705
Avg. Vol
88,862
88,862
52-wk High
$2.92
$2.92
52-wk Low
$1.00
$1.00
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 22.00 | 0.232 |
| Jun '18 | 0.00 | -0.124 | |
| Mar '18 | 0.00 | -0.182 | |
| FY 2017 | Dec '17 | 0.00 | 1.324 |
| Sep '17 | 6.00 | -0.140 | |
| Jun '17 | 0.00 | -0.336 | |
| Mar '17 | 0.00 | -0.208 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 3 | 0.71 | 2.00 | 0.00 | -- |
| Quarter Ending Jun-19 | 3 | 0.08 | 0.24 | 0.00 | -- |
| Year Ending Dec-19 | 4 | 0.84 | 2.00 | 0.00 | 0.00 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 4 | -0.17 | -0.15 | -0.20 | -- |
| Quarter Ending Jun-19 | 4 | -0.19 | -0.17 | -0.20 | -- |
| Year Ending Dec-19 | 4 | -0.74 | -0.70 | -0.79 | -1.04 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.71 | 33.71 | |
| P/E High - Last 5 Yrs. | -- | 147.99 | 49.93 | |
| P/E Low - Last 5 Yrs. | -- | 47.78 | 24.27 | |
| Beta | 2.69 | 1.08 | 0.90 | |
| Price to Sales (TTM) | -- | 49.51 | 6.28 | |
| Price to Book (MRQ) | 1.36 | 10.16 | 5.27 | |
| Price to Tangible Book (MRQ) | 1.37 | 13.82 | 6.78 | |
| Price to Cash Flow (TTM) | -- | 52.80 | 24.84 | |
| % Owned Institutions | 71.60 | 3.75 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.83 | |
| Payout Ratio(TTM) | -- | 7.04 | 41.08 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -100.00 | 130.05 | 9.73 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -100.00 | 47.86 | 5.88 | |
| Sales - 5 Yr. Growth Rate | -27.39 | 22.77 | 11.20 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -131.35 | 75.88 | 47.26 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -581.56 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 12.03 | 10.82 | |
| Capital Spending - 5 Yr. Growth Rate | -15.59 | 9.25 | 15.18 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.18 | 2.25 |
| Current Ratio (MRQ) | 6.29 | 3.43 | 3.08 |
| LT Debt to Equity (MRQ) | 35.31 | 18.73 | 11.39 |
| Total Debt to Equity (MRQ) | 36.09 | 31.43 | 16.13 |
| Interest Coverage (TTM) | -- | -43.27 | 29.51 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.29 | 53.79 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.55 | 52.17 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -146.16 | -110.24 | 12.87 | |
| Operating Margin (TTM) | -- | -184.42 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | -101.91 | -126.68 | 8.31 | |
| Pre-Tax Margin (TTM) | -- | -175.21 | 7.17 | |
| Pre-Tax Margin - 5 Yr. Avg. | -104.77 | -132.84 | 8.61 | |
| Net Profit Margin (TTM) | -- | -181.94 | 3.31 | |
| Net Profit Margin - 5 Yr. Avg. | -104.92 | -137.24 | 4.89 | |
| Effective Tax Rate (TTM) | -- | 21.48 | 22.88 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.57 | 23.39 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 0 | 7,651,352 | 844,195,039 | |
| Net Income/Employee (TTM) | -3,037,261 | 652,648 | 100,058,867 | |
| Receivable Turnover (TTM) | -- | 6.25 | 5.72 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.48 | |
| Asset Turnover (TTM) | 0.00 | 0.32 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -50.23 | 6.45 | 11.08 | |
| Return on Assets - 5 Yr. Avg. | -26.43 | 5.52 | 12.21 | |
| Return on Investment (TTM) | -62.67 | 8.99 | 14.48 | |
| Return on Investment - 5 Yr. Avg. | -30.82 | 6.86 | 15.88 | |
| Return on Equity (TTM) | -78.61 | 10.14 | 15.99 | |
| Return on Equity - 5 Yr. Avg. | -41.07 | 8.39 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -82.83 | -- | -27.39 |
| EPS (TTM) % | 76.80 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Infinity Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 31.40 | 26.87 | 99 | 99 |
| 13 Week | 5.30 | 0.17 | 99 | 95 |
| 26 Week | -34.30 | -39.29 | 37 | 98 |
| 52 Week | 3.25 | -12.49 | 99 | 72 |
| YTD | 17.78 | 3.43 | 99 | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 56.45% |
| # of Holders: | 77 |
| Total Shares Held: | 32,102,770 |
| 3 Mo. Net Change: | 1,869,055 |
| # New Positions: | 1 |
| # Closed Positions: | 2 |
| # Increased Positions: | 3 |
| # Reduced Positions: | 5 |
| # Net Buyers: | -2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.